Episode 36: How Safe Are Oral Corticosteroids? Jan/Feb 2023

Today we joined by Dr. Samanta Knox, MD from Gunderson Health System in La Crosse, WI where we review the Jan-Feb 2023 issue Allergy Watch, a bimonthly publication which provides research summaries to College members from the major journals in allergy and immunology.  You can earn CME credit by listening to this podcast! For information about CME credit, go to https://education.acaai.org/allergytalk. To read archived issues of Allergy Watch, head over to https://college.acaai.org/publications/allergywatch. Also, make sure you check out the ACAAI Community on DocMatter where we can continue the discussion about these articles! Articles Reviewed: Race and ethnicity define disparate clinical outcomes in chronic rhinosinusitis.   Atopic dermatitis and risk of autoimmune conditions: Population-based cohort study.   Low-dose oral corticosteroids in asthma associates with increased morbidity and mortality.   Please rate our podcast on iTunes! Please give us feedback, corrections, and suggestions! Email feedback to: [email protected] ACAAI is presenting this podcast for educational purposes only. It is not medical advice or intended to replace the judgment of a licensed physician. The College is not responsible for any claims related to procedures, professionals, products or methods discussed in the podcast, and it does not approve or endorse any products, professionals, services or methods that might be referenced. Today’s speakers have the following disclosures: Drs. Lee and Knox have nothing to disclose Dr. Fineman Speaker: Takeda; Research: Aimmune, DBV, Biocryst